Results 31 to 40 of about 7,604,553 (302)

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

open access: yesPLoS Medicine, 2012
The REMARK “elaboration and explanation” guideline, by Doug Altman and colleagues, provides a detailed reference for authors on important issues to consider when designing, conducting, and analyzing tumor marker prognostic studies.
D. Altman   +3 more
semanticscholar   +2 more sources

Detection of Microbial 16S rRNA Gene in the Serum of Patients With Gastric Cancer

open access: yesFrontiers in Oncology, 2019
Aberrance in the blood bacterial microbiome has been identified and validated in several non-infectious diseases, including cancer. The occurrence and progression of gastric cancer has been found to be associated with alterations in the microbiome ...
Zhaogang Dong   +24 more
doaj   +1 more source

Two-dimensional metal carbides and nitrides (MXenes): preparation, property, and applications in cancer therapy

open access: yesNanophotonics, 2020
Transition metal carbides and nitrides (MXenes), which comprise a rapidly growing family of two-dimensional materials, have attracted extensive attention of the scientific community, owing to its unique characteristics of high specific surface area ...
Dong Lu Ming   +4 more
doaj   +1 more source

lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma

open access: yesFrontiers in Cell and Developmental Biology, 2021
Long non-coding RNAs (lncRNAs) have emerged as useful prognostic markers in many tumors. In this study, we investigated the potential application of lncRNA markers for the prognostic prediction of esophageal squamous cell carcinoma (ESCC).
Shujun Zhang   +11 more
doaj   +1 more source

DNA Self-assembly Catalyzed by Artificial Agents

open access: yesScientific Reports, 2017
Nucleic acids have been shown to be versatile molecules and engineered to produce various nanostructures. However, the poor rate of these uncatalyzed nucleic acid reactions has restricted the development and applications.
Chao Shi   +3 more
doaj   +1 more source

Research on the effects of rs1800566 C/T polymorphism of NAD(P)H quinone oxidoreductase 1 gene on cancer risk involves analysis of 43,736 cancer cases and 56,173 controls

open access: yesFrontiers in Oncology, 2022
ObjectiveA two-electron reductase known as NQO1 [NAD(P)H quinone oxidoreductase 1] is regarded as an excellent anticancer target. Studies have found that rs1800566 polymorphism of NQO1 is linked to different cancers, but their associations remain ...
Hangsheng Zhou   +5 more
doaj   +1 more source

Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer

open access: yesFrontiers in Immunology, 2019
Tumor-infiltrating immune cells (TIICs) play essential roles in cancer development and progression. However, the association of TIICs with prognosis in colorectal cancer (CRC) patients remains elusive.
Lele Ye   +14 more
semanticscholar   +1 more source

Fabrication of an Electrochemical Biosensor Based on Nafion/Horseradish Peroxidase/Co3O4 NP/CILE and Its Electrocatalysis

open access: yesInternational Journal of Electrochemical Science, 2018
This paper focuses on the investigation of direct electrochemistry and electrocatalysis of horseradish peroxidase (HRP) on Co3O4 nanoparticles (NPs) decorated carbon ionic liquid electrode (CILE) as an electrochemical biosensor for determinations of ...
Wei Chen   +7 more
doaj   +1 more source

Squamous Cell Carcinoma Antigen: Clinical Application and Research Status

open access: yesDiagnostics, 2022
The squamous cell carcinoma antigen (SCCA) is a tumor marker that has gained increasing attention for its biological functions and significance in normal physiological and pathological processes.
Huange Zhu
doaj   +1 more source

Tumor associated antigens in diagnosis of serous effusions [PDF]

open access: yes, 1988
The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patients with benign and 200 patients with malignant disease.
Permanetter, W.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy